Peer-Reviewed Publication
A Targeted Boost-and-sort Immunization Strategy Using Escherichia Coli BamA Identifies Rare Growth Inhibitory Antibodies – May 8, 2018
Peer-Reviewed Publication
Antibody Responses to Crucial Functional Epitopes as a Novel Approach to Assess Immunogenicity of Vaccine Adjuvants – June 27, 2019
Peer-Reviewed Publication
Increased Breadth of HIV-1 Neutralization Achieved by Diverse Antibody Clones each with Limited Neutralization Breadth – December 19, 2018
Peer-Reviewed Publication
Massive Antibody Discovery Used to Probe Structure–function Relationships of the Essential Outer Membrane Protein LptD – June 25, 2019
Peer-Reviewed Publication
Massive Antibody Discovery Used to Probe Structure–function Relationships of the Essential Outer Membrane Protein LptD – June 25, 2019
Peer-Reviewed Publication
A Targeted Boost-and-sort Immunization Strategy Using Escherichia Coli BamA Identifies Rare Growth Inhibitory Antibodies – May 8, 2018
Peer-Reviewed Publication
Antibody Responses to Crucial Functional Epitopes as a Novel Approach to Assess Immunogenicity of Vaccine Adjuvants – June 27, 2019
Peer-Reviewed Publication
Increased Breadth of HIV-1 Neutralization Achieved by Diverse Antibody Clones each with Limited Neutralization Breadth – December 19, 2018
Application Note
Epitope Mapping of Peptide Libraries Using High Throughput SPR
Brochure
Carterra Brochure: Disruptive Drug Discovery Platforms for Screening and Characterization
Brochure
eBook: Streamlining Library-to-Lead for your Antibody Therapeutics
Poster
Accelerate Kinetic Screening and Epitope Characterization of Antibody Libraries with High Throughput SPR
Webinar
Characterization of Ion Channel Activity Blocking mAbs with High Throughput SPR – April 24, 2018
Learn how Tetragenetics has developed a strategy to generate and identify monoclonal antibodies targeting ion channels based on high-level expression of recombinant channels in Tetrahymena thermophila, enabling the development of potent immunogens and tools that allow deep mining of the immune repertoire.
Carterra’s LSA can analyze up to 384 binding interactions simultaneously, providing mAb characterization throughput to match the output of the current generation of mAb expression platforms; all antibodies can be rapidly and comprehensively screened so that unique epitopes and potential novel therapeutic candidates are not missed, while expanding IP coverage.
Speakers:
Paul Colussi, PhD, Vice President, Research, TetraGenetics
Yasmina Noubia Abdiche, PhD, Chief Scientific Officer, Carterra